Страна: Велика Британія
мова: англійська
Джерело: MHRA (Medicines & Healthcare Products Regulatory Agency)
Minoxidil
Pfizer Ltd
C02DC01
Minoxidil
2.5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050100; GTIN: 5012882005139
17.5” X 10” (FOLDED: 2.5” X 1”) DWG-100534-01 MULTIPLE INSERT EDITOR’S COPY GS: DATE: DIMENSIONS DRAWING NO. SKU NO. ITEM rev. 08JUN11 ADDITIONAL INFO: COLORS: Black MGR GS GA D. M. GUERIN B. NOEL D. HUFF REV _GA _ _PR _ _GS / ART REV (LCA) _ _GS / ART REV (FA)_ 1 MINIMUM TEXT FONT SIZE: 9 PT. NO CONDENSED. Dieline To avoid these problems, your doctor will prescribe two other medicines for you to take with LONITEN. One will be a water tablet (diuretic) to help your body get rid of excess water, and the other a beta-blocker or similar medicine to stop your heart beating too fast or angina pain in the chest. If your doctor gives you a low salt diet, follow it carefully. You should weigh yourself daily and keep an accurate record of your weight while you are taking this medicine. Tell your doctor if you put on more than 1 to 1.5 kg. The cause could be extra fluid in your body. Tell your doctor if you think you have gained weight – even though it may not be due to the medicine. Your doctor will want to monitor fluid and salt (electrolyte) levels in your body. You may recognise increased hair growth (hypertrichosis) after starting treatment, this usually emerges in the face but may subside with continued treatment. This side effect is reversible upon stopping treatment but may take one to six months. Your doctor will want to make regular checks on your blood pressure and general health. You should also have occasional checks on your heart. If you have an ECG test (to check the electrical activity of your heart) or any blood tests, remind your doctor that you are taking LONITEN, as it can change the results. Your doctor may monitor your blood for the very rare possibility of decreased white blood cells and platelets cells. In some patients, inflammation of membrane around heart, fluid accumulation under the membrane around heart (cardiac tamponade) can occur. Your doctor should monitor these carefully and may try to drain the fluid or may consider stopping treatment with LONITEN. Patients with kidney failur Прочитайте повний документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Loniten 2.5 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Loniten tablet contains 2.5 mg minoxidil. Excipients with known effect: Each tablet contains 95.8 mg of lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Round white to light tan biconvex tablets, with ‘2½' imprinted on one side, scored on the reverse with a ‘U’ on one side of the score and ‘121’ on the other side. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Minoxidil is indicated for the treatment of severe hypertension. It should not be used as the sole agent to initiate therapy. It is a peripheral vasodilator and should be given in conjunction with a diuretic, to control salt and water retention, and a beta adrenergic blocking agent, or appropriate substitute, to control reflex tachycardia. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Patients over 12 years and adults _ The recommended starting dose is 5 mg per day. If required, this dosage can later be increased up to 20 mg, and then to 40 mg daily (given as a single dose or in two divided doses). Dose increases should be made at increments of 5 mg to 10 mg minoxidil per day at intervals of three or more days. If a dose of 50 mg of minoxidil has been reached, the dose may be increased by 25 mg minoxidil per day to a maximum dose of 100 mg per day. If the desired decrease of diastolic blood pressure exceeds 30 mmHg, dosage should be divided to two daily doses to keep daily blood pressure fluctuations as low as possible. _Patients younger than 12 years of age _ The use of minoxidil in children is restricted to children with severe hypertension associated with target organ damage where other treatment has failed. The data regarding the use of minoxidil in children is very limited, especially in infants. The dosage recommendations can only be considered as a rough guide to treatment at present as this is base Прочитайте повний документ